US Pharmacopeia issues monographs on blood and blood-related products
Hormonal Contraceptive Use Increases Risk of Depression
Researchers explored whether or not hormonal contraceptive initiation is associated with increased risk of developing depression within 12 months of child delivery.
How LucyRx is Changing the Traditional PBM Model
LucyRx is empowering pharmacists and impacting patients’ health outcomes with its business model unlike other market-leading pharmacy benefit managers.
Study: CGMs Show Promise in Early Diagnostic of Type 2 Diabetes
This method supports improved, early detection for diabetes without relying on blood samples or complex procedures.
The Rise in Direct-to-Consumer Advertising of Prescription Drugs
Throughout her research, Jenny Markell, BA, has uncovered some alarming trends within prescription drug advertising in the US.
As a Result of PBM Reform, CVS Will Close Over 20 Pharmacies in Arkansas
CVS releases a statement shortly after HB1150 was signed in Arkansas, prohibiting pharmacy benefit managers from owning pharmacies.
Mark Cuban Cost Plus Drugs Provides More Cost Savings for Dermatology Prescription
Researchers conducted an observational cost analysis of dermatology drug savings between GoodRx and Mark Cuban Cost Plus Drug Company.
